Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	REGNRegeneron Pharmaceuticals	ARGXargenx SE	VRTXVertex Pharmaceuticals
Snapshot
Price	$808.70	$972.31	$519.39
Market cap	$68.59B	$55.53B	$115.02B
Valuation
P/E	19.1x	26x	28.7x
Forward P/E	18.3x	18.6x	27x
Growth
Revenue growth	5.9%	80.6%	10.1%
EPS growth	4.4%	111.4%	6.1%
Profitability
Net margin	29.6%	48.2%	35.5%
ROE	14.3%	22.9%	23.9%
Balance sheet & cash
Debt / equity	0.09x	0.01x	0.01x
Free cash flow yield	6.3%	—	3.1%
Dividend yield	0.6%	—	—
Verdict
Investment rating	Favorable· 69	Strong· 88	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	REGNtoday $809	ARGXtoday $972	VRTXtoday $519
2027	$633.21 – $928.71+15% CAGR	$1,541.74 – $2,261.22+133% CAGR	$413.38 – $606.29+17% CAGR
2028	$661.07 – $969.57+9% CAGR	$3,259.55 – $4,780.68+122% CAGR	$438.68 – $643.40+11% CAGR
2029	$690.16 – $1,012.24+8% CAGR	$6,891.35 – $10,107.31+118% CAGR	$465.53 – $682.78+10% CAGR
2030	$720.53 – $1,056.77+7% CAGR	$14,569.69 – $21,368.88+117% CAGR	$494.02 – $724.56+9% CAGR
2031	$752.23 – $1,103.27+6% CAGR	$30,803.24 – $45,178.08+115% CAGR	$524.25 – $768.90+8% CAGR
5-yr CAGR	-1.4% – 6.4%	99.6% – 115.5%	0.2% – 8.2%